Tech Company Financing Transactions
Ideal Option Funding Round
BlueCross BlueShield Venture Partners joined a funding round for Ideal Option. The funding round was announced by the company on 2/7/2019.
Transaction Overview
Company Name
Announced On
2/7/2019
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
BlueCross BlueShield Venture Partners (Binoy Bhansali)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
8508 W Gage Blvd. A101
Kennewick, WA 99336
USA
Kennewick, WA 99336
USA
Phone
Website
Email Address
Overview
Ideal Option has delivered personalized medicine to over 20,000 patients through a network of 60 urban and rural office-based opioid treatment (OBOT) clinics across 10 states. Ideal Option emphasizes individualized treatment programs for patients consisting of MAT and behavioral counseling services to drive superior outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Kilgallon
Chief Medical Officer
Jeffrey Allgaier
Chief Medical Officer
Kenneth Egli
VP - Operations
Bryce Kelly
VP - Operations
Wendy Manthei
Browse more venture capital transactions:
Prev: 2/7/2019: Calm venture capital transaction
Next: 2/7/2019: NuVera Medical venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs